Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol
- PMID: 16698719
- DOI: 10.1080/01926230600713632
Existence of no hepatocarcinogenic effect levels of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline with or without coadministration with ethanol
Abstract
There is increasing evidence of the existence of no effect levels for genotoxic carcinogens. However, only limited information is available regarding dose-response curves for combination effects of multiple carcinogens at low dose. In the present study, 280 male F344 rats were divided into 14 groups to determine the effects of co-administration of various doses of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) and 10% ethanol on the development of glutathione S-transferase placental form (GST-P)-positive foci in the liver. The results provided concrete evidence for the existence of no effect levels for hepatocarcinogenicity of MeIQx either in presence or absence of ethanol and, therefore, for a practical threshold for this genotoxic carcinogen.
Comment in
-
What is a practical threshold?Toxicol Pathol. 2007 Oct;35(6):848-9. doi: 10.1080/01926230701714844. Toxicol Pathol. 2007. PMID: 17987516 No abstract available.
Similar articles
-
Existence of no-observed effect levels for 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline on hepatic preneoplastic lesion development in BN rats.Cancer Lett. 2006 Jan 18;231(2):304-8. doi: 10.1016/j.canlet.2005.02.029. Cancer Lett. 2006. PMID: 16399231
-
Evidence of a threshold-effect for 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline liver carcinogenicity in F344/DuCrj rats.Toxicol Pathol. 2008 Apr;36(3):472-7. doi: 10.1177/0192623308315671. Epub 2008 Apr 15. Toxicol Pathol. 2008. PMID: 18413788
-
No-observed effect levels for carcinogenicity and for in vivo mutagenicity of a genotoxic carcinogen.Toxicol Sci. 2004 Oct;81(2):273-9. doi: 10.1093/toxsci/kfh241. Epub 2004 Jul 28. Toxicol Sci. 2004. PMID: 15282409
-
Qualitative and quantitative approaches in the dose-response assessment of genotoxic carcinogens.Mutagenesis. 2016 May;31(3):341-6. doi: 10.1093/mutage/gev049. Epub 2015 Jul 7. Mutagenesis. 2016. PMID: 26152227 Review.
-
Current and emerging challenges in toxicopathology: carcinogenic threshold of phenobarbital and proof of arsenic carcinogenicity using rat medium-term bioassays for carcinogens.Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):225-9. doi: 10.1016/j.taap.2005.01.037. Toxicol Appl Pharmacol. 2005. PMID: 15993454 Review.
Cited by
-
In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling.Cancers (Basel). 2021 Nov 8;13(21):5583. doi: 10.3390/cancers13215583. Cancers (Basel). 2021. PMID: 34771745 Free PMC article. Review.
-
Science and policy on endocrine disrupters must not be mixed: a reply to a "common sense" intervention by toxicology journal editors.Environ Health. 2013 Aug 27;12:69. doi: 10.1186/1476-069X-12-69. Environ Health. 2013. PMID: 23981490 Free PMC article.
-
Chronic ethanol intake promotes double gluthatione S-transferase/transforming growth factor-alpha-positive hepatocellular lesions in male Wistar rats.Cancer Sci. 2008 Feb;99(2):221-8. doi: 10.1111/j.1349-7006.2007.00677.x. Cancer Sci. 2008. PMID: 18271918 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials